Deutsche Bank’s AbCellera Biologics ABCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-194,032
Closed -$1.25M 3694
2023
Q2
$1.25M Sell
194,032
-109,438
-36% -$747K ﹤0.01% 1862
2023
Q1
$2.29M Buy
303,470
+84,850
+39% +$770K ﹤0.01% 1612
2022
Q4
$2.21M Buy
218,620
+24,984
+13% +$289K ﹤0.01% 1603
2022
Q3
$1.92M Buy
193,636
+3,920
+2% +$43K ﹤0.01% 1646
2022
Q2
$2.02M Buy
189,716
+79,610
+72% +$674K ﹤0.01% 1746
2022
Q1
$1.07M Buy
+110,106
New +$1.04M ﹤0.01% 2297
2021
Q4
Sell
-6,888
Closed -$138K 4232
2021
Q3
$138K Buy
+6,888
New +$122K ﹤0.01% 3748
2021
Q2
Sell
-2,395
Closed -$81K 4576
2021
Q1
$81K Buy
+2,395
New +$95.4K ﹤0.01% 4085

Other funds holding ABCL